Revance to Present New DAXXIFY Data at the American Academy of Neurology 2024 Annual Meeting
12.04.2024 - Revance Therapeutics, Inc. (NASDAQ: RVNC), today announced two poster presentations on DAXXIFY for the treatment of cervical dystonia at the annual meeting of American Academy of Neurology (AAN), taking place April 13-18, 2024, in Denver, Colorado. ... Seite 1